3i Germany puts DM5m (E2.6m) into GenPat77 Pharmacogenetics
The company develops treatments that assist patients dependent on immune therapies.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
- Database
- LP search
- GP search
- Fund search
- Commitments New
- Investment Consultant search
- Placement Agent search
- Law Firm search
- Live Fundraising Chart
- Benchmarks
- Institution Profiles Index
- Private Equity Data
- Investor Calendar 2025
- Update your database profile
- Law firm data submission
- Database key terms and methodology
- Fund performance methodology
- Quick Search
- PEI Awards 2025: Send us your submissions!
- PEI 300: The World’s Largest Private Equity Firms
- Side Letter
- Friday Letters
- Guest Comment
- Private Equity Investor Intentions and Preferences
- The Democratisation of Private Equity
- Magazine
- LP Perspectives 2025
- Meet the LP Series
- Top Private Equity Placement Agents
- Secondaries
- Performance
- Latest News & Analysis
- Rankings & Reports
- Events
- Bookstore
- Podcasts
